Cellulite Treatment Market Research Report Information By Treatment Procedure (Non-Invasive, Minimally-Invasive, Topical Treatment), By Cellulite Type (Hard Cellulite, Soft Cellulite, Edematous Cellulite), By End Use (Hospitals, Ambulatory Surgical Centers, Specialized Dermatology Clinics), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING NUMBER OF OBESE CASES ACROSS THE GLOBE

4.2.2 RISING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES

4.2.3 GROWING MEDICAL TOURISM INDUSTRY

4.3 RESTRAINTS

4.3.1 CONCERNS PERTAINING TO BRUISING AND SWELLING

4.3.2 SHORTAGE OF TRAINED AND EXPERIENCED DERMATOLOGIST/ PLASTIC SURGEON

4.4 OPPORTUNITY

4.4.1 GROWING ADOPTION OF COSMETIC PROCEDURES IN EMERGING ECONOMIES

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION AND SALES

5.1.4 POST-SALES MONITORING

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF SUPPLIERS

5.2.2 BARGAINING POWER OF BUYERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL CELLULITE TREATMENT MARKET

5.3.1 IMPACT ON SUPPLY CHAIN

5.3.2 IMPACT ON PATIENTS SUFFERING FROM CELLULITE

5.3.3 IMPACT ON DEMAND AND SUPPLY

5.3.4 IMPACT ON REGIONS

6 GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE

6.1 OVERVIEW

6.2 NON-INVASIVE

6.3 TOPICAL

6.4 MINIMALLY INVASIVE

6.5 OTHERS

7 GLOBAL CELLULITE TREATMENT MARKET, BY CELLULITE TYPE

7.1 OVERVIEW

7.2 SOFT CELLULITE

7.3 HARD CELLULITE

7.4 EDEMATOUS CELLULITE

8 GLOBAL CELLULITE TREATMENT MARKET, BY END USER

8.1 OVERVIEW

8.2 HOSPITALS

8.3 SPECIALISED DERMATOLOGY CLINICS

8.4 AMBULATORY SURGICAL CENTERS

8.5 OTHERS

9 GLOBAL CELLULITE TREATMENT MARKET, BY REGION

9.1 OVERVIEW

9.2 NORTH AMERICA

9.2.1 US

9.2.2 CANADA

9.3 EUROPE

9.3.1 GERMANY

9.3.2 UK

9.3.3 FRANCE

9.3.4 ITALY

9.3.5 SPAIN

9.3.6 REST OF EUROPE

9.4 ASIA PACIFIC

9.4.1 CHINA

9.4.2 JAPAN

9.4.3 INDIA

9.4.4 SOUTH KOREA

9.4.5 AUSTRALIA

9.4.6 REST OF ASIA PACIFIC

9.5 REST OF THE WORLD

9.5.1 MIDDLE EAST

9.5.2 AFRICA

9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW

10.2 COMPETITIVE BENCHMARKING

10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CELLULITE TREATMENT MARKET

10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL CELLULITE TREATMENT MARKET

10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES

10.5.1 PRODUCT LAUNCH/PRODUCT APPROVAL

11 COMPANY PROFILES

11.1 HOLOGIC, INC.

11.1.1 COMPANY OVERVIEW

11.1.2 FINANCIAL OVERVIEW

11.1.3 PRODUCTS/SERVICES OFFERED

11.1.4 KEY DEVELOPMENTS

11.1.5 SWOT ANALYSIS

11.1.6 KEY STRATEGIES

11.2 NUBWAY CO.LTD.

11.2.1 COMPANY OVERVIEW

11.2.2 FINANCIAL OVERVIEW

11.2.3 PRODUCTS/SERVICES OFFERED

11.2.4 KEY DEVELOPMENTS

11.2.5 SWOT ANALYSIS

11.2.6 KEY STRATEGIES

11.3 MERZ PHARMA GMBH & CO. KGAA

11.3.1 COMPANY OVERVIEW

11.3.2 FINANCIAL OVERVIEW

11.3.3 PRODUCTS/SERVICES OFFERED

11.3.4 KEY DEVELOPMENTS

11.3.5 SWOT ANALYSIS

11.3.6 KEY STRATEGIES

11.4 ZIMMER AESTHETICS

11.4.1 COMPANY OVERVIEW

11.4.2 FINANCIAL OVERVIEW

11.4.3 PRODUCTS/SERVICES OFFERED

11.4.4 KEY DEVELOPMENTS

11.4.5 SWOT ANALYSIS

11.4.6 KEY STRATEGIES

11.5 CYMEDICS

11.5.1 COMPANY OVERVIEW

11.5.2 FINANCIAL OVERVIEW

11.5.3 PRODUCTS/SERVICES OFFERED

11.5.4 KEY DEVELOPMENTS

11.5.5 SWOT ANALYSIS

11.5.6 KEY STRATEGIES

11.6 CYNOSURE, LLC

11.6.1 COMPANY OVERVIEW

11.6.2 FINANCIAL OVERVIEW

11.6.3 PRODUCTS/SERVICES OFFERED

11.6.4 KEY DEVELOPMENTS

11.6.5 KEY STRATEGIES

11.7 INCELER MEDIKAL CO. LTD.

11.7.1 COMPANY OVERVIEW

11.7.2 FINANCIAL OVERVIEW

11.7.3 PRODUCTS/SERVICES OFFERED

11.7.4 KEY DEVELOPMENTS

11.7.5 KEY STRATEGIES

11.8 CANDELA MEDICAL

11.8.1 COMPANY OVERVIEW

11.8.2 FINANCIAL OVERVIEW

11.8.3 PRODUCTS/SERVICES OFFERED

11.8.4 KEY DEVELOPMENTS

11.8.5 KEY STRATEGIES

11.9 CUTERA, INC.

11.9.1 COMPANY OVERVIEW

11.9.2 FINANCIAL OVERVIEW

11.9.3 PRODUCTS/SERVICES OFFERED

11.9.4 KEY DEVELOPMENTS

11.9.5 KEY STRATEGIES

11.10 BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.

11.10.1 COMPANY OVERVIEW

11.10.2 FINANCIAL OVERVIEW

11.10.3 PRODUCTS/SERVICES OFFERED

11.10.4 KEY DEVELOPMENTS

11.10.5 KEY STRATEGIES

12 APPENDIX

12.1 REFERENCES

12.2 RELATED REPORTS

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 GLOBAL: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 4 GLOBAL: CELLULITE TREATMENT MARKET, FOR NON-INVASIVE, BY REGION, 2018–2027 (USD MILLION)

TABLE 5 GLOBAL: CELLULITE TREATMENT MARKET, FOR TOPICAL, BY REGION, 2018–2027 (USD MILLION)

TABLE 6 GLOBAL: CELLULITE TREATMENT MARKET, FOR MINIMALLY INVASIVE, BY REGION, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: CELLULITE TREATMENT MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: CELLULITE TREATMENT MARKET, FOR SOFT CELLULITE, BY REGION, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: CELLULITE TREATMENT MARKET, FOR HARD CELLULITE, BY REGION, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL: CELLULITE TREATMENT MARKET, FOR EDEMATOUS CELLULITE, BY REGION, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 13 GLOBAL: CELLULITE TREATMENT MARKET, FOR HOSPITALS, BY REGION, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL: CELLULITE TREATMENT MARKET, FOR SPECIALISED DERMATOLOGY CLINICS, BY REGION, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL: CELLULITE TREATMENT MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL: CELLULITE TREATMENT MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL: CELLULITE TREATMENT MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 18 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 19 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 20 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 21 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 22 US: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 23 US: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 24 US: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 25 CANADA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 26 CANADA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 27 CANADA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 28 EUROPE: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 29 EUROPE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 30 EUROPE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 31 EUROPE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 32 GERMANY: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 33 GERMANY: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 34 GERMANY: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 35 UK: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 36 UK: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 37 UK: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 38 FRANCE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 39 FRANCE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 40 FRANCE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 41 ITALY: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 42 ITALY: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 43 ITALY: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 44 SPAIN: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 45 SPAIN: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 46 SPAIN: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 47 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 48 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 49 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 50 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 51 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 52 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 53 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 54 CHINA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 55 CHINA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 56 CHINA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 57 JAPAN: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 58 JAPAN: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 59 JAPAN: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 60 INDIA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 61 INDIA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 62 INDIA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 63 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 64 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 65 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 66 AUSTRALIA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 67 AUSTRALIA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 68 AUSTRALIA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 69 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 70 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 71 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 72 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 73 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 74 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 75 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 76 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 77 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 78 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 79 AFRICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 80 AFRICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 81 AFRICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 82 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)

TABLE 83 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)

TABLE 84 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 85 MAJOR PLAYERS IN THE GLOBAL CELLULITE TREATMENT MARKET

TABLE 86 MOST ACTIVE PLAYER IN THE GLOBAL CELLULITE TREATMENT MARKET

TABLE 87 PRODUCT LAUNCH/PRODUCT APPROVAL

TABLE 88 HOLOGIC, INC: PRODUCTS/SERVICES OFFERED

TABLE 89 NUBWAY CO.LTD.: PRODUCTS/SERVICES OFFERED

TABLE 90 MERZ PHARMA GMBH & CO. KGAA: PRODUCTS/SERVICES OFFERED

TABLE 91 ZIMMER AESTHETICS: PRODUCTS/SERVICES OFFERED

TABLE 92 CYMEDICS: PRODUCTS/SERVICES OFFERED

TABLE 93 CYNOSURE, LLC: PRODUCTS/SERVICES OFFERED

TABLE 94 INCELER MEDIKAL CO. LTD.: PRODUCTS/SERVICES OFFERED

TABLE 95 CANDELA MEDICAL: PRODUCTS/SERVICES OFFERED

TABLE 96 CUTERA, INC.: PRODUCTS/SERVICES OFFERED

TABLE 97 CUTERA, INC.: KEY DEVELOPMENTS

TABLE 98 BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.: PRODUCTS/SERVICES OFFERED

LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 MARKET STRUCTURE: GLOBAL CELLULITE TREATMENT MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL CELLULITE TREATMENT MARKET

FIGURE 5 DRIVER IMPACT ANALYSIS

FIGURE 6 RESTRAINT IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL CELLULITE TREATMENT MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CELLULITE TREATMENT MARKET

FIGURE 9 GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2020 & 2027 (USD MILLION)

FIGURE 10 GLOBAL: CELLULITE TREATMENT MARKET, CELLULITE TYPE, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL: CELLULITE TREATMENT MARKET, END USER, 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL: CELLULITE TREATMENT MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 13 GLOBAL: CELLULITE TREATMENT MARKET SHARE (%), BY REGION, 2020

FIGURE 14 NORTH AMERICA: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020

FIGURE 15 EUROPE: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020

FIGURE 16 ASIA PACIFIC: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020

FIGURE 17 REST OF THE WORLD: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020

FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 19 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CELLULITE TREATMENT MARKET

FIGURE 20 HOLOGIC, INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 21 HOLOGIC, INC: SWOT ANALYSIS

FIGURE 22 NUBWAY CO.LTD.: SWOT ANALYSIS

FIGURE 23 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS

FIGURE 24 ZIMMER AESTHETICS: SWOT ANALYSIS

FIGURE 25 CYMEDICS: SWOT ANALYSIS